ClinicalTrials.Veeva

Menu
S

San Juan Bautista School of Medicine | Clinical Research Unit

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Linaclotide
Guselkumab
Linagliptin
Methotrexate
Mesalamine
Empagliflozin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 8 total trials

A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease (GALAXI)

The purpose of this study is to evaluate the clinical efficacy (GALAXI 1), clinical and endoscopic efficacy (GALAXI 2 and GALAXI 3) and safety of gus...

Active, not recruiting
Crohn's Disease
Drug: Ustekinumab
Drug: Guselkumab Dose 3

Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD) characterized by diffuse, continuous inflammation of the colon. This study will...

Not yet enrolling
Ulcerative Colitis (UC)
Drug: Placebo
Drug: Mesalamine

LIN-MD-66 is a Phase 3 open-label study with 24 weeks (Functional Constipation participants) or 52 weeks (Irritable bowel syndrome with constipation...

Active, not recruiting
Functional Constipation
Irritable Bowel Syndrome With Constipation
Drug: Functional Constipation (FC) participants (LIN-MD-62 and LIN-MD-64 completers)
Drug: Irritable Bowel Syndrome with Constipation (IBS-C) participants (LIN-MD-63 completers)

Trial sponsors

AbbVie logo
Abbott logo
Boehringer Ingelheim logo
Janssen (J&J Innovative Medicine) logo
Mass General Brigham logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems